SUPPLEMENTAL EQUITY INFORMATION (Tables)

12 Months Ended

Dec. 29, 2019

SUPPLEMENTAL EQUITY INFORMATION

Schedule of components of accumulated other comprehensive loss, net of tax

			Other
	Minimum		Comprehensive
	Pension and		Loss
	Post-		Related to
	Retirement		Equity
(in thousands)	Liability		Investments		Total
Balance at December 31, 2017	$	(442,406)	$	(6,963)	$	(449,369)
Amounts reclassified from AOCL		(153,414)		(1,506)		(154,920)
Other comprehensive income		(153,414)		(1,506)		(154,920)
Balance at December 30, 2018	$	(595,820)	$	(8,469)	$	(604,289)
Other comprehensive income (loss) before reclassifications		7,021		—		7,021
Amounts reclassified from AOCL		21,129		—		21,129
Other comprehensive income		28,150		—		28,150
Balance at December 29, 2019	$	(567,670)	$	(8,469)	$	(576,139)

Schedule of reclassification out of accumulated other comprehensive income

	Amount Reclassified from AOCL (in thousands)
	Year Ended		Year Ended
	December 29,		December 30,		Affected Line in the
AOCL Component	2019		2018		Consolidated Statements of Operations
Minimum pension and post-retirement liability	$	21,129	$	(56,530)	Retirement benefit expense (1)
Reclassification of AOCL tax effects		—		(98,390)	Retained earnings (2)
	$	21,129	$	(154,920)	Net of tax

_____________________

⁽¹⁾ There is no income tax benefit associated with the years ended December 29, 2019 and December 30, 2018, due to the recognition of a valuation allowance.

⁽²⁾ See Note 3, Income Taxes regarding the Tax Act.

Summary of anti-dilutive stock options

	Years Ended
	December 29,	December 30,
(shares in thousands)	2019	2018
Anti-dilutive common stock equivalents	471	199

Summary of the restricted stock units ("RSUs") activity

		Weighted
		Average Grant
		Date Fair
	RSUs	Value
Nonvested — December 31, 2017	245,794	$	11.55
Granted	278,130	$	8.90
Vested	(167,722)	$	11.38
Forfeited	(24,602)	$	9.54
Nonvested — December 30, 2018	331,600	$	9.56
Granted	285,771	$	5.58
Vested	(172,297)	$	9.59
Forfeited	(31,608)	$	6.96
Nonvested — December 29, 2019	413,466	$	7.00

Summary of the stock appreciation rights ("SARs") activity

		Weighted		Aggregate
		Average		Intrinsic Value
	SARs	Exercise Price		(in thousands)
Outstanding December 31, 2017	156,175	$	32.12	$	—
Expired	(42,875)	$	32.09
Outstanding December 30, 2018	113,300	$	32.13	$	—
Expired	(24,425)	$	34.02
Outstanding December 29, 2019	88,875	$	31.61	$	—
SARs exercisable:
December 30, 2018	113,300			$	—
December 29, 2019	88,875			$	—

Summary of information about SARs outstanding in the stock plans

		Average
		Remaining	Weighted			Weighted
Range of Exercise	SARs	Contractual	Average		SARs	Average
Prices	Outstanding	Life	Exercise Price		Exercisable	Exercise Price
$24.60 – $40.80	88,875	1.50	$	31.61	88,875	$	31.61
Total	88,875	1.50	$	31.61	88,875	$	31.61

Summary of stock-based compensation expense

	Years Ended
	December 29,		December 30,
(in thousands)	2019		2018
Stock-based compensation expense	$	1,504	$	2,057